DNA strand

The Preclinical Research Resource (PRR) has a cancer translational research-centered mission to facilitate the use of patient-derived xenograft (PDX) models, genetically engineered mouse models (GEMMs), and other relevant mouse cancer models in preclinical drug development and identification of relevant biomarkers for treatment selection and evaluation.

We provide start-to-finish services for in vivo experimentation, including experimental design consultation, tumor cell transplant, tumor growth monitoring and imaging, preparation of therapeutic agents, harvested tissues, and interpretation of results.

Contact

Preclinical Research Resource Director
David H Lum, PhD
david.lum@hci.utah.edu
801-213-5663

Associate Director
Kate Modzelewska, PhD
Kate.Modzelewska@hci.utah.edu

Lab Contact
prr@hci.utah.edu

Governance

HCI Senior Director Oversight
Martin McMahon, PhD

Faculty Advisory Committee Chair
Sheri Holmen, PhD

Faculty Advisory Committee Members
Neeraj Agarwal, MD
Ignacio Garrido-Laguna, MD, PhD
Margit Janat-Amsbury, MD, PhD
Charles Murtaugh, PhD
Eric Snyder, MD, PhD
Alana Welm, PhD